This is a novel biomarker that may interest several AD researchers as the selective targeting of several neurotrophin receptors has been proposed as a viable mechanism of intervention for neuroprotection [51]–[56] (with much of the attention being on the p75(NTR), the common neurotrophin receptor [53], [57]–[66]). The gene discussed is NGFR; the disease is Alzheimer disease.